For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260331:nRSe7008Ya&default-theme=true
RNS Number : 7008Y Manolete Partners PLC 31 March 2026
31 March 2026
Manolete Partners PLC
("Manolete" or the "Company")
Directorate Changes
Manolete is delighted to announce the appointment of Marcia Shekerdemian KC to
the Board as a Non-Executive Director with effect from 31 March 2026.
Marcia is a leading barrister in all aspects of contentious and
non-contentious insolvency, company and partnership law as well as commercial
litigation. She sat in the High Court as a Deputy Insolvency and Companies
Court Judge from 2000 to 2025, and remains in private practice as a barrister
as a member of Wilberforce Chambers. Marcia will join the Audit Committee and
chair the Remuneration Committee.
She will replace Dr. Stephen Baister on the Board, who will step down as a
Non-Executive Director with effect from the same date. Stephen will continue
to provide consultancy to the Company.
Lord Leigh of Hurley, Chairman of Manolete said:
"I am delighted that Marcia has agreed to join the Board. She brings extensive
knowledge across insolvency litigation and I look forward to working with her
over the coming years.
"I would also like to thank Stephen for his work as a senior adviser to
Manolete and then as a Non-Executive Director since 2018. His knowledge of
insolvency law and critical thinking have been very important to the Board. I
am pleased that he will continue to deliver the benefits of his deep expertise
as a consultant to the Company."
Marcia Shekerdemian KC, commenting on her appointment as a Non-Executive
Director of Manolete said:
"As the UK's leading insolvency claims financing company, Manolete is
deservedly well-known and respected for the quality and efficacy of its work
helping creditors increase returns on claims that otherwise wouldn't be
pursued. The Company has a proven, unique business model and I am looking
forward to supporting the Board to build on Manolete's growth to date."
The following information is disclosed pursuant to paragraph (g) of Schedule 2
to the AIM Rules:
Marcia Shekerdemian KC aged 62 is currently a director of Middle Temple
Charity, and in the last 5 years has been a director of the Leonard Cheshire
Disability Charity. There are no further items to be disclosed.
For further information please contact:
Manolete Partners
Mena Halton (Chief Executive Officer) via Houston
Will Sawyer (Chief Financial Officer)
Canaccord (NOMAD and Sole Broker) +44 (0)20 7523 8000
Stuart Andrews
Emma Gabriel
Harry Rees
Houston (Financial PR)
+44 (0)77 3303 2695
Charlie
Barker
+44 (0)20 4529 0549
Nick Jackman
Manolete@houston.co.uk (mailto:Manolete@houston.co.uk)
About Manolete Partners PLC
Manolete Partners Plc is the UK's leading insolvency claims financing company.
Serving a growing market worth over £500 million annually, the Company has a
highly experienced team with coverage across the UK and a proven track record
of generating strong historic returns across over 1,300 cases financed and
completed to date.
Widely recognised as the industry leader, Manolete is the only company in the
insolvency litigation funding section to be ranked in Band 1 of the legal
industry's prestigious Chambers Guide five times. The Company is also
five-time winner of 'Insolvency Litigation Funder of the Year' at the
Turnaround, Restructuring and Insolvency Industry Awards.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOABLGDXGXXDGLG
Copyright 2019 Regulatory News Service, all rights reserved